Significant Increase in Salivary Substance P Level after a Single Oral Dose of Cevimeline in Humans

Cevimeline is a novel muscarinic acetylcholine receptor agonist currently being developed as a therapeutic agent for xerostomia. We examined the effects of cevimeline on salivary and plasma levels of substance-P- (SP-), calcitonin-gene-related-peptide- (CGRP-), and vasoactive-intestinal-polypeptide-...

Descripción completa

Detalles Bibliográficos
Autores principales: Suzuki, Yosuke, Itoh, Hiroki, Amada, Kohei, Yamamura, Ryota, Sato, Yuhki, Takeyama, Masaharu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2013
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3621173/
https://www.ncbi.nlm.nih.gov/pubmed/23589717
http://dx.doi.org/10.1155/2013/284765

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3621173/
https://www.ncbi.nlm.nih.gov/pubmed/23589717
http://dx.doi.org/10.1155/2013/284765

Ejemplares similares